CAPREIT Announces October 2021 Distribution

Written by Customer Service on October 15, 2021. Posted in Dividend Reports And Estimates.

TORONTO, Oct. 15, 2021 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX – CAR.UN) announced today its October 2021 monthly distribution in the amount of $0.12084 per Unit (or $1.45 on an annualized basis). The October distribution will be payable on November 15, 2021 to Unitholders of record on October 29, 2021. To encourage participation and reward our loyal Unitholders, investors registered in our Distribution Reinvestment Plan will continue to receive an additional amount equal to 5% of their distributions paid in the form of additional Units. CAPREIT is Canada’s largest publicly-traded provider of quality rental housing. CAPREIT currently owns or has interests in, and manages, approximately 70,000 residential apartment suites, townhomes and manufactured housing community sites well-located...

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

Written by Customer Service on October 15, 2021. Posted in Earnings Releases And Operating Results.

OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) — Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2021. Financial Results RevenueConsolidated revenues for the third quarter of fiscal 2021 were $7.5 million compared to $8.1 million for the third quarter of fiscal 2020. The revenues for the third quarter of fiscal 2021 consisted of $7.3 million in processing and storage fees, $18,200 in product revenue and $158,936 in public banking revenue compared $7.5 million in processing and storage fees, $427,874 in licensee income, $82,800 in product revenue and $116,826 in public banking revenue for the third quarter of fiscal 2020. Net Income The Company reported...

Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the American Society of Nephrology (ASN) Kidney Week 2021

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Additional data to be presented from the ongoing phase 1/2 study of BION-1301 in patients with IgA nephropathy, including biomarker and proteinuria reductions Several presentations on the atrasentan clinical program, including translational research demonstrating ETA activation is associated with clinical progression in IgA nephropathy Chinook to host investor conference call and webcast on November 4, 2021 to review abstracts and provide updates on the company’s pipeline SEATTLE, Oct. 15, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced upcoming presentations at ASN Kidney Week 2021 from November 4-7, 2021. The six abstracts covering the BION-1301 and atrasentan...

Nabriva Therapeutics to Present Data at CHEST Annual Meeting 2021

Written by Customer Service on October 15, 2021. Posted in Public Companies.

DUBLIN, Ireland and FORT WASHINGTON, Pa., Oct. 15, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today, announced data presentation at CHEST 2021, the annual meeting of the American College of CHEST Physicians, which will be held virtually October 17-20. On behalf of Nabriva, Dr. Thomas M. File, MD, MS, FCCP will participate in a live oral session on Lefamulin Efficacy and Safety in Adults with Community-Acquired Bacterial Pneumonia: Pooled Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Trials in Patients with Multilobar or Unilobar Pneumonia. XENLETA® (lefamulin) is a first-in-class pleuromutilin antibiotic for the treatment of community-acquired...

GPM Announces Special Distribution Amount

Written by Customer Service on October 15, 2021. Posted in Dividend Reports And Estimates.

NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) — Guggenheim Enhanced Equity Income Fund (“GPM” or the “Fund”) today announced the final amount of the previously-declared special distribution. The final amount of GPM’s special distribution will be $0.34 per share. The table below summarizes the distribution schedule for the Fund. GPM’s special distribution will be a cash only distribution. The following dates apply to the GPM special distribution (as announced on October 11, 2021): Record Date October 19, 2021 Ex-Dividend Date October 18, 2021 Payable Date October 21, 2021 As previously announced on August 24, 2021, GPM shareholders approved a merger of the Fund with and into Guggenheim Strategic Opportunities Fund (“GOF”) to be effective with the open of the New York Stock Exchange on October 25, 2021, subject to the satisfaction...

Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin Pharmaceuticals

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) — Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the previously announced strategic merger with privately-held Quoin Pharmaceuticals, Inc., a specialty pharmaceutical company focused on rare and orphan diseases (the “Merger”) and the sale of the Company’s subsidiary, Cellect Biotherapeutics Ltd., to EnCellX, Inc., a privately held company based in San Diego, CA (the “Share Transfer”). Upon the closings of the Merger and Share Transfer, the Depositary for the Company’s American Depositary Shares (“ADS”), as the holder of the Company’s ordinary shares, will become entitled to one CVR for each ordinary share outstanding. Following the closings,...

Frequency Electronics, Inc. Announces Award of a Contract for Space-qualified Oscillators

Written by Customer Service on October 15, 2021. Posted in Public Companies.

MITCHEL FIELD, N.Y., Oct. 15, 2021 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) announced the award of a contract for space-qualified precision oscillators for ultimate application to a government satellite program. This order is an exercise of options on a current contract. Value of the award is approx. $5.3m. The contract period of performance runs through October of 2024. No further details of the award are being released. FEI CEO Stan Sloane commented, “We are extremely pleased that one of our key customers has exercised contract options, reflecting continued satisfaction with FEI’s products and delivery performance. This award will result in even more FEI products being incorporated into critical satellites that support our warfighters and an ever-growing number of FEI products in space.” About...

Freddie Mac Prices $724 Million Multifamily K-Deal, K-HG3, Backed by Properties Controlled by Harbor Group International, LLC

Written by Customer Service on October 15, 2021. Posted in Public Companies.

MCLEAN, Va., Oct. 15, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), backed by a multifamily mortgage loan with one fixed rate component and two floating rate components. The approximately $724 million in K Certificates (K-HG3 Certificates) are backed by 41 properties indirectly controlled by Harbor Group International, LLC, or its affiliates. K-HG3 is expected to settle on or about October 21, 2021. The transaction collateral is part of Freddie Mac’s single-asset, single borrower (SASB) execution. The SASB execution transfers first loss credit risk on either one or multiple properties owned or controlled by a single sponsorship group. K-HG3 Pricing Class Principal/Notional Amount (mm) Weighted Average Life (Years) Spread (bps) Coupon Yield Dollar...

Urbana Corporation Net Asset Value per Share above $7 – Sets New All-time High

Written by Customer Service on October 15, 2021. Posted in Public Companies.

/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, Oct. 15, 2021 (GLOBE NEWSWIRE) — Urbana Corporation (“Urbana”) (TSX and CSE: URB, URB.A) is pleased to announce that as of the close October 14th, 2021, its net asset value per share (“NAVPS”) reached a new all-time high of $7.02, exceeding $7 for the first time. Total net assets for Urbana are now over $300 million. Urbana’s NAVPS at the end of 2020 was $5.64, prior to our $0.09 per share dividend in January 2021. Much of the contribution to this year’s growth has been from our large U.S. financial positions, the energy sector and especially Urbana’s private investments. Urbana’s largest private investment is CNSX Markets Inc., the operator of the Canadian Securities Exchange. Urbana’s current private holdings include Tetra...

HUMBL and BLOCKS Announce Strategic Collaboration on Blockchain Initiatives

Written by Customer Service on October 15, 2021. Posted in Public Companies.

San Diego, California, Oct. 15, 2021 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC Markets: HMBL), a consumer blockchain company working to simplify use cases across verticals like payments, ticketing and NFTs, today announced their collaboration with a decentralized blockchain project called BLOCKS. BLOCKS is one of the world’s first Wyoming DAO, LLCs, created to provide a US-based, decentralized blockchain network that will use a combination of BLOCKS, bridges and sidechains to improve the use of blockchain by consumers, corporations and governments. The BLOCKS and HUMBL teams have already begun experimenting with the use of bridges, and sidechains to reduce gas fees on NFTs by up to 98%, improve NFT metadata storage across modalities like music and video, and create an improved “Verified by BLOCKS” registry to help customers authenticate,...

Day: October 15, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice